Cathie Wood's position in Vertex Pharmaceuticals is currently worth $11.4 Million. That's 0.10% of their equity portfolio (84th largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2020. Since then Cathie Wood bought shares five more times and sold shares on thirteen occasions. The stake costed the investor $5.99 Million, netting the investor a gain of 91% so far.
Even with the wider market rebound, Cathie Wood hasn’t quite recaptured her initial investment allure. Her flagship fund, the ARK Innovation ETF (NYSEARCA: A...
Love her or loathe her, Cathie Wood’s magnetic pull on the investment world remains undiminished. Wood has uniquely curated portfolios brimming with disrupti...